GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Motif Bio PLC (NAS:MTFB) » Definitions » Beta

Motif Bio (Motif Bio) Beta : N/A (As of May. 07, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Motif Bio Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-07), Motif Bio's Beta is Not available.


Motif Bio Beta Historical Data

The historical data trend for Motif Bio's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Motif Bio Beta Chart

Motif Bio Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Motif Bio Semi-Annual Data
Dec11 Dec12 Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Motif Bio's Beta

For the Shell Companies subindustry, Motif Bio's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Motif Bio's Beta Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Motif Bio's Beta distribution charts can be found below:

* The bar in red indicates where Motif Bio's Beta falls into.



Motif Bio Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Motif Bio  (NAS:MTFB) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Motif Bio Beta Related Terms

Thank you for viewing the detailed overview of Motif Bio's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Motif Bio (Motif Bio) Business Description

Traded in Other Exchanges
N/A
Address
3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT
Motif Bio PLC is a cash shell company.

Motif Bio (Motif Bio) Headlines

From GuruFocus

Motif Bio to Present Iclaprim Data at ECCMID 2019

By Marketwired Marketwired 04-04-2019

Motif Bio Conference Call and Webcast

By Marketwired Marketwired 02-19-2019

Motif Bio to Present Iclaprim Data at ASM Microbe 2019

By Marketwired Marketwired 05-21-2019

NIH to Evaluate Iclaprim Activity against Listeria

By Marketwired Marketwired 08-19-2019

Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim

By Marketwired Marketwired 03-20-2019

Motif Bio Receives Complete Response Letter from the FDA

By Marketwired Marketwired 02-14-2019

Motif Bio and Hercules Capital Amend Loan and Security Agreement

By Marketwired Marketwired 08-01-2019